CRITICAL ANALYSIS OF PALLIATION PRODUCED BY ADRENALECTOMY IN METASTATIC CANCER OF THE FEMALE BREAST
Authors: S KOFMAN, D NAGAMANI, C P PERLIA, S G TAYLOR
Journal: Annals of Internal Medicine (1956)

Article1 December 1956CRITICAL ANALYSIS OF PALLIATION PRODUCED BY ADRENALECTOMY IN METASTATIC CANCER OF THE FEMALE BREASTCHARLES P. PERLIA, M.D., SYDNEY KOFMAN, M.D., DEVANABOYINA NAGAMANI, M.D., SAMUEL G. TAYLOR III, M.D., F.A.C.P.CHARLES P. PERLIA, M.D.Search for more papers by this author, SYDNEY KOFMAN, M.D.Search for more papers by this author, DEVANABOYINA NAGAMANI, M.D.Search for more papers by this author, SAMUEL G. TAYLOR III, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-45-6-989 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONIn the absence of any definitive cure, retardation of tumor growth with prolongation of a comfortable and useful life is a worth while achievement in the treatment of patients with metastatic cancer. In women, carcinoma of the breast is one of the most common forms of malignant disease, with a high incidence of generalized dissemination and long-lasting terminal disability. Any means of producing reasonably prolonged and successful palliation is highly gratifying to both patient and physician. It is the more desirable to the latter if it can be ascribed to a specific antitumor effect of the therapy used. There...Bibliography1. HugginsDao CTL: Characteristics of adrenal dependent mammary cancer, Ann. Surg. 140: 497, 1954. CrossrefMedlineGoogle Scholar2. GalanteRukesForshamWoodBell MJMPHWAHG: Bilateral adrenalectomy for advanced cancer of the breast with preliminary observations on the effects of the liver on the metabolism of adrenal cortical steroids, Ann. Surg. 140: 502, 1954. CrossrefMedlineGoogle Scholar3. GalanteMcCorkle MHJ: Clinical evaluation of bilateral adrenalectomy and oophorectomy for advanced mammary carcinoma, Am. J. Surg. 90: 180, 1955. CrossrefMedlineGoogle Scholar4. Cade S: Adrenalectomy for breast cancer, Brit. M. J. 1: 1, 1955. CrossrefMedlineGoogle Scholar5. Cade S: Adrenalectomy for hormone dependent cancers: breast and prostate, Ann. Roy. Coll. Surgeons, England 15: 71, 1954. MedlineGoogle Scholar6. Delarue NC: Results of estrogen deprivation therapy in metastatic mammary carcinoma, Canad. M. A. J. 73: 641, 1955. MedlineGoogle Scholar7. PearsonWestLiMcLeanTreves OHCDMCJPN: Endocrine therapy of metastatic breast cancer, Arch. Int. Med. 95: 357, 1955. CrossrefGoogle Scholar8. PyrahSmiddy LNFG: Mammary cancer treated by bilateral adrenalectomy, Lancet 1: 1041, 1954. CrossrefGoogle Scholar9. Hellström J: Bilaterala adrenalektomier vid metastaserande cancer mammae, Nord. med. 53: 632, 1955. MedlineGoogle Scholar10. TaylorLiEcklesSlaughterMcDonald SGMCNDPJH: Effect of surgical Addison's disease on advanced carcinoma of the breast and prostate, Cancer 6: 997, 1953. CrossrefMedlineGoogle Scholar11. PearsonWhitmoreWestFarronRandall OHWFCDJHHT: Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man, Surgery 34: 543, 1953. MedlineGoogle Scholar12. LaszloSchulmanBellinHermanSchilling DCAJEDA: Mineral and protein metabolism in osteolytic metastasis, J. A. M. A. 148: 1027, 1952. CrossrefMedlineGoogle Scholar13. PearsonWestHollanderTreves OHCDVPNE: Evaluation of endocrine therapy for advanced breast cancer, J. A. M. A. 154: 234, 1954. CrossrefMedlineGoogle Scholar14. EmersonJessiman KAG: Hormonal influences on the growth and progression of cancer, New England J. Med. 254: 252, 1956. CrossrefMedlineGoogle Scholar15. PearsonLiMcLeanLipsettWest OHMCJPMBCD: Management of metastatic mammary cancer, J. A. M. A. 159: 1701, 1955. MedlineGoogle Scholar16. Petrakis NL: Bone marrow pressure in leukemic and non-leukemic patients, J. Clin. Investigation 33: 27, 1954. CrossrefMedlineGoogle Scholar17. HallbergNohrmanSylvén OBB: Survival time in women with disseminated breast cancer following testosterone treatment, Acta radiol. 39: 161, 1953. CrossrefMedlineGoogle Scholar18. Knapp EL: Factors influencing the urinary excretion of calcium, J. Clin. Investigation 26: 182, 1947. CrossrefGoogle Scholar19. MeiselasGoldner LEMG: Failure of calcium tolerance test as a diagnostic aid in malignant metastatic disease, Metabolism 4: 250, 1955. MedlineGoogle Scholar20. BauerAlbrightAub WFJC: Studies on calcium and phosphorus metabolism, J. Clin. Investigation 7: 75, 1929. CrossrefMedlineGoogle Scholar21. DeitrickWhedonShorr JEGDE: Effects of immobilization upon various metabolic and physiologic functions of normal men, Am. J. Med. 4: 3, 1948. CrossrefMedlineGoogle Scholar22. AbramsSpiroGoldstein HLRN: Metastasis in carcinoma: analysis of 1000 autopsied cases, Cancer 3: 74, 1950. CrossrefMedlineGoogle Scholar23. FreidGoldberg JRH: Treatment of metastases from cancer of breast, Am. J. Roentgenol. 63: 312, 1950. Google Scholar24. GriboffHerrmannSmelinMoss SIJBAJ: Hypercalcemia secondary to bone metastases from carcinoma of the breast; relationship between serum calcium and alkaline phosphatase values, J. Clin. Endocrinol. and Metab. 14: 378-388 (Apr.) 1954. CrossrefGoogle Scholar25. Woodward HQ: Changes in blood chemistry associated with carcinoma metastatic to bone, Cancer 6: 1219, 1953. CrossrefMedlineGoogle Scholar26. KennedyNathansonTibbettsAub BJITDMJC: Biochemical alterations during steroid hormone therapy of advanced breast cancer, Am. J. Med. 19: 337, 1955. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Chicago, Illinois*Received for publication April 17, 1956.From the Departments of Medicine and Surgery and the Tumor Clinic of the Research and Educational Hospitals and Presbyterian Hospital, Chicago, Illinois.The work has been supported in part by funds from the Lucia Winston Memorial Fund and the Illinois Division of the American Cancer Society.Requests for reprints should be addressed to Samuel G. Taylor, III, M.D., The Presbyterian Hospital of the City of Chicago, 1753 West Congress Street, Chicago 12, Illinois. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAdvanced Breast CancerSelection and treatment of patients with advanced breast cancerSurvival of patients with “recurrent” or inoperable carcinoma of the breast with special consideration of the effect of hormonal treatment.A study of 338 casesMedical treatment of cancer of the breast and prostateResults of bilateral adrenalectomy in the management of incurable breast cancer.Report of 155 casesAn evaluation of therapeutic surgical castration in the treatment of metastatic, recurrent, and primary inoperable mammary carcinoma in women. An analysis of 191 patientsThe use of prednisolone in the treatment of disseminated breast carcinomaSurgical Endocrine Ablation for Advanced Breast CancerAnticoagulants in Reconstructive Vascular SurgeryThe Jugular Venous Pulse 1 December 1956Volume 45, Issue 6Page: 989-1000KeywordsCalciumCancer treatmentDisabilitiesExcretionHormonal therapyHospital medicineMetastasisPatientsPhosphatasesSurgery ePublished: 1 December 2008 Issue Published: 1 December 1956 PDF downloadLoading ...